# Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design

**Authors:** Alan M Rice, Atahualpa Castillo Morales, Alexander T Ho, Christine Mordstein, Stefanie Mühlhausen, Samir Watson, Laura Cano, Bethan Young, Grzegorz Kudla, Laurence D Hurst

PMC · DOI: 10.1093/molbev/msaa188 · Molecular Biology and Evolution · 2020-07-20

## TL;DR

This study finds that SARS-CoV-2 has a mutation bias toward uracil (U) but is selected against it, which could inform better vaccine design strategies.

## Contribution

The paper identifies a strong mutation bias toward U and selection against it in SARS-CoV-2, offering new insights for vaccine attenuation.

## Key findings

- SARS-CoV-2 shows a strong mutation bias toward uracil (U) at synonymous sites.
- Observed UU content is only a quarter of what is expected under neutrality, indicating selection against U.
- CpG content varies systematically between SARS-CoV-2 genes, suggesting gene-specific selection.

## Abstract

Large-scale re-engineering of synonymous sites is a promising strategy to generate vaccines either through synthesis of attenuated viruses or via codon-optimized genes in DNA vaccines. Attenuation typically relies on deoptimization of codon pairs and maximization of CpG dinucleotide frequencies. So as to formulate evolutionarily informed attenuation strategies that aim to force nucleotide usage against the direction favored by selection, here, we examine available whole-genome sequences of SARS-CoV-2 to infer patterns of mutation and selection on synonymous sites. Analysis of mutational profiles indicates a strong mutation bias toward U. In turn, analysis of observed synonymous site composition implicates selection against U. Accounting for dinucleotide effects reinforces this conclusion, observed UU content being a quarter of that expected under neutrality. Possible mechanisms of selection against U mutations include selection for higher expression, for high mRNA stability or lower immunogenicity of viral genes. Consistent with gene-specific selection against CpG dinucleotides, we observe systematic differences of CpG content between SARS-CoV-2 genes. We propose an evolutionarily informed approach to attenuation that, unusually, seeks to increase usage of the already most common synonymous codons. Comparable analysis of H1N1 and Ebola finds that GC3 deviated from neutral equilibrium is not a universal feature, cautioning against generalization of results.

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** ORF7a (ORF7a protein) [NCBI Gene 43740573], S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, NEU1 (neuraminidase 1) [NCBI Gene 4758] {aka NANH, NEU, SIAL1}, TLR7 (toll like receptor 7) [NCBI Gene 51284] {aka IMD74, SLEB17, TLR7-like}, PRAP1 (proline rich acidic protein 1) [NCBI Gene 118471] {aka PRO1195, UPA}, ORF1ab (ORF1a polyprotein;ORF1ab polyprotein) [NCBI Gene 43740578], OLFM4 (olfactomedin 4) [NCBI Gene 10562] {aka GC1, GW112, OLM4, OlfD, UNQ362, bA209J19.1}, E (envelope protein) [NCBI Gene 43740570], ORF7b (ORF7b) [NCBI Gene 43740574], RNASEL (ribonuclease L) [NCBI Gene 6041] {aka PRCA1, RNS4}, ZC3HAV1 (zinc finger CCCH-type containing, antiviral 1) [NCBI Gene 56829] {aka ARTD13, FLB6421, PARP13, ZAP, ZC3H2, ZC3HDC2}, ORF6 (ORF6 protein) [NCBI Gene 43740572], IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, ORF10 (ORF10 protein) [NCBI Gene 43740576], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, SLC25A18 (solute carrier family 25 member 18) [NCBI Gene 83733] {aka GC2}
- **Diseases:** sars-cov-2 (MESH:D000094024), SARS (MESH:D045169), U (MESH:C536925), inflammatory (MESH:D007249), Ebola (MESH:D019142), COVID-19 (MESH:D000086382)
- **Chemicals:** NO (MESH:D009614), dinucleotide (MESH:D015226), A (MESH:D001151), C (MESH:D002244), U (MESH:D014501), guanosine (MESH:D006151), N (MESH:D009584), ApU (-), GC (MESH:C057580),  (MESH:D014498)
- **Species:** Severe acute respiratory syndrome-related coronavirus (no rank) [taxon 694009], EBOV [taxon 186536], Ebola virus (no rank) [taxon 1570291], H1N1 subtype (serotype) [taxon 114727], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G at codon position +1, 1-A-C, C at codon position 2
- **Cell lines:** Vero — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_0059)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC7454790/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7454790/full.md

## References

81 references — full list in the complete paper: https://tomesphere.com/paper/PMC7454790/full.md

---
Source: https://tomesphere.com/paper/PMC7454790